Werewolf Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
USA Life Sciences Database,
- Progressing Phase 1/1b clinical trial for IL-2 INDUKINE WTX-124 in advanced or metastatic solid tumors; initial first-in-human…